期刊文献+

鼻咽癌患者生存质量FACT-H&N量表测评 被引量:30

Validation of functional assessment of cancer therapy-head and neck (FACT-H&N) scale(Chinese version) for measuring quality of life in patients with nasopharyngeal carcinoma
原文传递
导出
摘要 目的应用头颈部肿瘤患者生存质量测定量表(FACT-H&N)对鼻咽癌患者生存质量进行测评。方法选取中山大学肿瘤医院确诊的鼻咽癌患者444例,采用FACT-H&N量表进行生存质量测评,同时评价量表信度与效度。结果治疗中患者生理状况得分为(19.08±5.454)分;功能状况得分为(14.00±5.490)分;头颈部附加条目得分为(20.11±6.052)分;量表总得分为(95.18±18.360)分;均低于治疗前和治疗后得分;治疗后患者头颈部附加条目得分和生存质量总得分虽比治疗中有所上升,但未恢复至治疗前水平;量表内部一致性信度(克朗巴赫系数)为0.899,量表各领域的克朗巴赫系数(Cronbachα)为0.692~0.859;生理状况、功能状况和头颈部附加条目3个领域的重测相关系数(r)均>0.5,相关性良好;提取5个公因子的累积方差贡献率为61%,与量表设计基本吻合。结论治疗中的鼻咽癌患者生存质量明显下降;FACT-H&N量表可用于鼻咽癌患者生存质量测定和相关研究。 Objective To assess the validity of the functional assessment of cancer therapy-head and neck (FACT- H&N) (Chinese version) in patients with nasopharyngeal carcinoma. Methods Four hundred and forty four patients com- pleted FACT-H&N scale. The internal consistency for the total scale and its subscales were assessed with Cronbach's alpha. Test-retest reliability was determined with paired t-test and Person correlation. The data were analyzed with exploratory fac- tor analysis to determine factor construct validity. Inter-subscale correlations were analyzed with Person correlation and com- pared with the Cronbach's alpha of each subscale. Scores of the patients before, under, and after treatment were compared with analysis of variance. Results The scores of the physical well-being, functional well-being and the additional head and neck items during treatment period decreased compared with that of pre-treatment and post-treatment periods. The total score of the whole questionnaire didn' t increase to the same level of the pre-treatment period. Cronbach's ct coefficient of the total scale was 0. 899 and that of for the five domains ranged from 0. 692 to 0. 859. Test-retest showed good reproducibility. Five factors were extracted by exploratory factor analysis in accord with the questionnaire. Correlation coefficients between one subscale and others were less than Cronbach's α coefficient of that subscale. Conclusion The total scale is valid for measuring quality of life in patients with nasopharyngeal carcinoma with good reliability, validity and responsiveness.
出处 《中国公共卫生》 CAS CSCD 北大核心 2010年第7期827-829,共3页 Chinese Journal of Public Health
关键词 生存质量 问卷调查 鼻咽癌 头颈部肿瘤患者生存质量测定量表(FACT-H&N) quality of life questionnaire investigation nasopharyngeal carcinoma FACT-H&N
  • 相关文献

参考文献9

  • 1Chong VF,Ong CK. Nasopharyngeal carcinoma[ J]. Eur J Radiol, 2008,66(3 ) :437 -447.
  • 2杨云利,朱小东.鼻咽癌放射治疗后患者生存质量的研究[J].肿瘤研究与临床,2006,18(5):351-353. 被引量:15
  • 3Rogers SN,Ahad SA,Murphy AP. A structured review and theme analysis of papers published on ' quality of life' in head and neck cancer:2000 -2005[J]. Oral Oncol,2007,43(9) :843 -868.
  • 4Huang WW,Zhou FS ,Bushnell DM,et al. Cultural adaptation and application of the IBS-QOL in China:a disease-specifie quality-of- life questionnaire[J]. Qual Life Res. 2007,16 (6) :991 - 996.
  • 5Lee AW, Lau WH, Tung SY, ctal. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally -advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group [ J ]. J Clin Oncol,2005,23 ( 28 ) :6966 - 6975.
  • 6万崇华,孟琼,汤学良,张灿珍,罗家洪,张晓磐.癌症患者生命质量测定量表FACT-G中文版评介[J].实用肿瘤杂志,2006,21(1):77-80. 被引量:416
  • 7万崇华,陈明清,张灿珍,汤学良,孟琼,张晓磬.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-355. 被引量:1312
  • 8Yoo H, Suh C, Kim S, et al. Korean translation and validation of the functional assessment of cancer therapy-lung (FACT-L) version 4[ J]. Qual Life Res,2006,15 ( 1 ) :161 - 166.
  • 9Conroy T, Mercier M, Bonneterm J, et al. French version of FACT- G: validation and comparison with other cancer-specific instruments[ J]. Eur J Cancer,2004,40( 15 ) :2243 - 2252.

二级参考文献15

  • 1陈志玲,陈朝红.鼻咽癌患者放疗的观察及护理[J].中华护理杂志,1994,29(6):343-345. 被引量:8
  • 2罗健,孙燕.癌症患者的生活质量研究[J].国外医学(肿瘤学分册),1995,22(2):109-112. 被引量:46
  • 3陈和年,胡孟璇,洪明晃,方积乾,谢方云,毛志达,闵华庆.鼻咽癌生存质量量表的研究[J].中华预防医学杂志,1996,30(4):229-230. 被引量:40
  • 4Johnson JR,Temple R.Food and Drug Administration requirements for approval of new anticancer drugs [J].Cancer Treat Rep,1985,69(10):1155-1159.
  • 5Celia DE,Tulsky DS,Gray G,et al.The Functional Assessment of Cancer Therapy scale:development and validation of the general measure [J].J Clin Onco1,1993,11(3):570-579.
  • 6Johnson JR,Temple R. Food and drug administration requirements for approval of new anti-cancer drugs[J]. Cancer Treat Rep, 1985,69(10) : 1155-1157.
  • 7Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30:a quality of life instrument for use in international clinical trials in oncology [J]. J Natl Cancer Inst, 1993,85 (5) : 365-376.
  • 8Aaronson NK, Cull A, Kaasa S, et al. The EORTC modular approach to quality of life assessment in ontology [J]. Int J Ment Health, 1994,23 (4):75-96.
  • 9Aaronson N K,Meyerowitz B E,Bard M,et al.Quality of life research in oncology[J].Cancer,1991,67(3 Suppl):839-843.
  • 10Dimery I W,Peters L J,Goepfert H,et al.Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma[J].Clin Oncol,1993,11(10):1919-1928.

共引文献1714

同被引文献328

引证文献30

二级引证文献420

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部